{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+B+Placebo&page=2", "query": { "intervention": "Part B Placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+B+Placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-24T16:55:22.749Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07250750", "title": "A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "IM-101 Part A", "type": "DRUG" }, { "name": "Placebo Part A", "type": "DRUG" }, { "name": "IM-101 Part B", "type": "DRUG" }, { "name": "Placebo Part B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ImmunAbs Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 96, "start_date": "2026-02-05", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-02-11", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 8, "location_summary": "Altamonte Springs, Florida • Boca Raton, Florida • Naples, Florida + 4 more", "locations": [ { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "Port Charlotte", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07250750" }, { "nct_id": "NCT04676685", "title": "A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "E2730", "type": "DRUG" }, { "name": "E2730-matched placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2020-12-16", "completion_date": "2021-06-23", "has_results": false, "last_update_posted_date": "2021-08-26", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04676685" }, { "nct_id": "NCT07220785", "title": "Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Lipodystrophy" ], "interventions": [ { "name": "Mibavademab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 28, "start_date": "2026-03-13", "completion_date": "2028-09-08", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan • Dallas, Texas", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07220785" }, { "nct_id": "NCT07090785", "title": "A Study of LY4088044 in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "LY4088044", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 104, "start_date": "2025-07-24", "completion_date": "2027-07", "has_results": false, "last_update_posted_date": "2026-08-07", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 4, "location_summary": "Los Alamitos, California • Lenexa, Kansas • San Antonio, Texas + 1 more", "locations": [ { "city": "Los Alamitos", "state": "California" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07090785" }, { "nct_id": "NCT05924815", "title": "Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Aficamten", "type": "DRUG" }, { "name": "Aficamten-matching Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 44, "start_date": "2023-05-15", "completion_date": "2023-11-14", "has_results": false, "last_update_posted_date": "2023-12-19", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05924815" }, { "nct_id": "NCT05972993", "title": "A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "mRNA-CR-04 vaccine 10μg", "type": "BIOLOGICAL" }, { "name": "mRNA-CR-04 vaccine 30μg", "type": "BIOLOGICAL" }, { "name": "mRNA-CR-04 vaccine 100μg", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "mRNA-CR-04 vaccine 3μg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 114, "start_date": "2023-08-07", "completion_date": "2024-10-14", "has_results": true, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 4, "location_summary": "San Diego, California • Melbourne, Florida • Peoria, Illinois + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05972993" }, { "nct_id": "NCT07028749", "title": "Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertriglyceridemia" ], "interventions": [ { "name": "MAR001", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marea Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 316, "start_date": "2025-06-30", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 26, "location_summary": "Anniston, Alabama • Mobile, Alabama • Little Rock, Arkansas + 23 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07028749" }, { "nct_id": "NCT04508179", "title": "A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "7HP349 Single Ascending Dose", "type": "DRUG" }, { "name": "7HP349 Multiple Ascending Dose", "type": "DRUG" }, { "name": "Placebo Single Ascending Dose", "type": "DRUG" }, { "name": "Placebo Multiple Ascending Dose", "type": "DRUG" }, { "name": "7HP349 Food Effect", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "7 Hills Pharma, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 60, "start_date": "2020-10-28", "completion_date": "2021-10-25", "has_results": false, "last_update_posted_date": "2021-11-02", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 1, "location_summary": "Secaucus, New Jersey", "locations": [ { "city": "Secaucus", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04508179" }, { "nct_id": "NCT07196046", "title": "Product Responsiveness to Enhanced Bioavailability Curcumin Dietary Supplements in Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Joint Discomfort", "Quality of Life (QOL)" ], "interventions": [ { "name": "Supplement 2", "type": "DIETARY_SUPPLEMENT" }, { "name": "Supplement 3", "type": "DIETARY_SUPPLEMENT" }, { "name": "Supplement 1", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Ultra Botanica LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 30, "start_date": "2025-12-10", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT07196046" }, { "nct_id": "NCT02626455", "title": "Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma, Non-Hodgkin" ], "interventions": [ { "name": "Copanlisib (BAY80-6946)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Bendamustine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 551, "start_date": "2016-01-06", "completion_date": "2023-11-10", "has_results": true, "last_update_posted_date": "2024-12-11", "last_synced_at": "2026-09-24T16:55:22.749Z", "location_count": 10, "location_summary": "Chandler, Arizona • West Covina, California • Denver, Colorado + 6 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "West Covina", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Thomasville", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02626455" } ] }